Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc

Bullboard Posts

Post by brianpearton Dec 10, 2015 7:50pm

126 Views

Post# 24375183

Spectral Medical - Don't forget us poor Canadians.

I don't think Canada will approve the treatment until the FDA does. A good friend died last summer and the Doctors treating him didn't seem to know about this proposed treatment. In view of the extensive use in Europe and Japan it would be nice to have some alternative available or at least find out what the problem is.

Bullboard Posts

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!